Filing Details
- Accession Number:
- 0001077183-21-000134
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-27 18:23:32
- Reporting Period:
- 2021-05-25
- Accepted Time:
- 2021-05-27 18:23:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1621453 | J. Robert Shovlin | 12701 Commonwealth Drive Suite 9 Fort Myers FL 33913 | President, Clinical Services | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-25 | 96,167 | $8.03 | 249,914 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-05-25 | 16,724 | $19.60 | 266,638 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-05-25 | 14,067 | $28.33 | 280,705 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-25 | 130,604 | $39.31 | 150,101 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-05-25 | 96,167 | $0.00 | 96,167 | $8.03 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-05-25 | 16,724 | $0.00 | 16,724 | $19.60 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-05-25 | 14,067 | $0.00 | 14,067 | $28.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-02-26 | No | 4 | M | Direct | |
| 33,449 | 2024-03-01 | No | 4 | M | Direct | |
| 42,204 | 2027-03-02 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $53.17 | 2028-03-02 | 38,688 | 38,688 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2028-03-02 | 38,688 | 38,688 | Direct |
Footnotes
- On March 2, 2021, Mr. Shovlin was granted 38,688 stock options. These options vest ratably over the first four anniversary dates of the grant date
- On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Billionaire Hedge Funds
